The safety of rituximab for the treatment of autoimmune blistering diseases: a systematic review

Publication History

Accepted: June 22, 2021

Received in revised form: May 19, 2021

Received: November 15, 2020

Publication stageIn Press Journal Pre-ProofFootnotes

All authors deny any potential conflicts of interest, sources of funding and/or other relationships requiring disclosure. No funding was secured for this study.

Contributors’ Statements

Mr. Mohammed assisted with the search, excluded studies, assessed data, conceptualized the report, and reviewed and revised the manuscript.

Dr. Hekman conceptualized the report, assessed data, and reviewed and revised the manuscript.

Dr. Li assessed search data and excluded studies.

Ms. Misquith performed the search and conceptualized the search strategy.

Dr. Rahnama-Moghadam conceptualized the report and reviewed and revised the manuscript.

All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.

Acknowledgements:

The authors would like to thank Rick Ralston at the Ruth Lilly Medical Library, Indiana University School of Medicine, for peer-reviewing the primary search strategy in MEDLINE (Ovid).

Identification

DOI: https://doi.org/10.1016/j.jaad.2021.06.862

Copyright

© 2021 Published by Elsevier on behalf of the American Academy of Dermatology, Inc.

ScienceDirectAccess this article on ScienceDirect

留言 (0)

沒有登入
gif